BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21403827)

  • 21. Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.
    Lubet RA; Scheiman JM; Bode A; White J; Minasian L; Juliana MM; Boring DL; Steele VE; Grubbs CJ
    Cancer Prev Res (Phila); 2015 Apr; 8(4):296-302. PubMed ID: 25762530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model.
    Fernandes JC; Sereno J; Garrido P; Parada B; Cunha MF; Reis F; Pintado ME; Santos-Silva A
    Mar Drugs; 2012 Dec; 10(12):2661-75. PubMed ID: 23342389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
    Kunze E; Schulz H; Adamek M; Gabius HJ
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model.
    Bidinotto LT; Spinardi-Barbisan AL; Rocha NS; Salvadori DM; Barbisan LF
    Environ Mol Mutagen; 2006 Oct; 47(8):624-30. PubMed ID: 16878317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of liarozole on the cell proliferation activity in the rat urinary bladder epithelium induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Nagae H; Otawara Y; Suzuki K; Fujita K
    Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):838-42. PubMed ID: 10565163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemopreventive Efficacy of Thymoquinone in Chemically Induced Urinary Bladder Carcinogenesis in Rat.
    Hamaamin KS; Marouf BH
    Biomed Res Int; 2022; 2022():6276768. PubMed ID: 36158887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells.
    Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW
    Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effects of IFN on N-butyl-N-(hydroxybutyl) nitrosamine induced rats bladder tumors].
    Yasumoto R; Asakawa M; Fukui J; Wada S; Kishimoto T; Maekawa M
    Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):16-22. PubMed ID: 1564822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H
    Jpn J Cancer Res; 2002 Jan; 93(1):42-9. PubMed ID: 11802807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.
    Lubet RA; Clapper ML; McCormick DL; Pereira MA; Chang WC; Steele VE; Fischer SM; Juliana MM; Grubbs CJ
    Oncol Rep; 2012 May; 27(5):1400-6. PubMed ID: 22307264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats.
    Galant LW; de Mattos AA; Menti E; Valiatti FB; de Mattos AZ; Porawski M; Hartmann A; Rhoden CR
    Ann Hepatol; 2013; 12(3):425-33. PubMed ID: 23619259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
    Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
    Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
    Bhattacharya A; Li Y; Shi Y; Zhang Y
    Carcinogenesis; 2013 Nov; 34(11):2593-9. PubMed ID: 23946495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
    Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N
    Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
    Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
    Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.